Patent ID: 7342026

Claim:
A method for treating protozoan and retrovirus co-infections in an individual which comprises administering to said individual at least one quinoline corresponding to general formula (I): in which: R 1 represents: a hydrogen atom, a C 1 -C 15 alkyl group, a C 2 -C 15 alkenyl group, a C 2 -C 15 alkynyl group, a formyl group, a heteroaryl group, or a heteroaryl group substituted with one or more hydroxyl groups; or else a C 1 -C 15 alkyl or C 2 -C 7 alkenyl group carrying at least one substituent chosen from oxygen, halogens, and hydroxyl, formyl, carboxyl, aryloxycarbonyl, C 2 -C 8 alkyloxycarbonyl, C 3 -C 9 alkenyloxycarbonyl, nitrile, amine, C 1 -C 7 alkoxy, phenoxy, C 3 -C 6 cycloalkyl, aryl, heteroaryl, heteroaryloxy, arylsulfone, C 1 -C 7 alkylsulfone, C 1 -C 7 thioalkyl and C 1 -C 7 aminoalkyl groups; or else a C 2 -C 7 alkynyl group carrying at least one substituent chosen from oxygen, halogens, and hydroxyl, formyl, carboxyl, aryloxycarbonyl, C 2 -C 8 alkyloxycarbonyl, C 3 -C 9 alkenyloxycarbonyl, nitrile, aryl, heteroaryl, arylsulfone, C 1 -C 7 alkylsulfone, C 1 -C 7 thioalkyl and C 1 -C 7 aminoalkyl groups; or else a C 2 -C 15 alkenyl or alkynyl group substituted with at least one C 1 -C 7 trialkylsilyl group; while R 2 , which may be in the 3-, 6- or 8-position of the quinoline ring, represents a hydrogen or halogen atom, a hydroxyl group, formyl group, carboxyl group, C 1 -C 7 alkyl group, C 1 -C 7 alkoxy group, amine group, C 1 -C 10 alkylamide group, C 2 -C 7 alkenyl group, a C 2 -C 7 alkenyl group substituted with one or more C 1 -C 7 alkoxy groups, a C 2 -C 10 alkynyl group, or a C 2 -C 10 alkynyl group substituted with a heteroaryl group; or one of its pharmaceutically acceptable salts, on the condition, however, that R 1 and R 2 are not both a hydrogen atom, in a pharmaceutically acceptable carrier.